Applied Genetic Technologies reported $-15639000 in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Applied Genetic Technologies AGTC:US $ -15.64M 2.66M
Avrobio Inc AVRO:US $ -32246000 1.17M
Biogen BIIB:US $ 991.8M 155.8M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Celldex Therapeutics CLDX:US $ -16.57M 3.9M
Cti Biopharma CTIC:US $ -23.25M 3.87M
Gilead Sciences GILD:US $ 4370M 1605M
Insmed INSM:US $ -91545000 6.9M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Life Technologies LIFE:US $ -7.6M 2.72M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Rigel Pharmaceuticals RIGL:US $ -19.52M 6.73M
Ultragenyx Pharmaceutical RARE:US $ -86.61M 6.96M